JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diop, S.
Right arrow Articles by Gessain, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diop, S.
Right arrow Articles by Gessain, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2006, p. 1550-1554, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1550-1554.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Seroprevalence and Molecular Epidemiology of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 in Blood Donors from Dakar, Senegal

Saliou Diop,1 Sara Calattini,2 Julienne Abah-Dakou,1 Doudou Thiam,1 Lamine Diakhaté,1 and Antoine Gessain2*

Centre National de Transfusion Sanguine, Ave. Cheikh Anta Diop, Fann, BP 5002 Dakar, Sénégal,1 Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département Ecosytèmes et Epidémiologie des Maladies Infectieuses, Institut Pasteur, 75015 Paris, France2

Received 24 October 2005/ Returned for modification 13 January 2006/ Accepted 20 January 2006

In 2002, human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 seroprevalence was 0.16% (8/4,900) in blood donors from Dakar, Senegal. Most of the positive donors originated from the country’s southern region. Seven donors were infected by HTLV-1 (of cosmopolitan subtype), and one was infected by HTLV-2. These data highlight the problem of transfusion safety in this area where HTLV-1-associated lymphoproliferative and neurological diseases are endemic.

* Corresponding author. Mailing address: Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département Ecosytèmes et Epidémiologie des Maladies Infectieuses, Batiment Lwoff, Institut Pasteur, 25-28 Rue du Dr. Roux, 75724 Paris, Cedex 15, France. Phone: 33 (0)1 45 68 89 37. Fax: 33 (0)1 40 61 34 65. E-mail: agessain{at}pasteur.fr.

Journal of Clinical Microbiology, April 2006, p. 1550-1554, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1550-1554.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.